This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1984:15:279-82.

The effect of ticlopidine on TIA compared with aspirin: a double-blind, twelve-month follow-up study

H Tohgi

PMID: 6385652

Clinical Trial

The effect of ticlopidine on TIA compared with aspirin: a double-blind, twelve-month follow-up study

H Tohgi. Agents Actions Suppl. 1984.

. 1984:15:279-82.

Author

H Tohgi

PMID: 6385652

No abstract available

PubMed Disclaimer

Similar articles

Ticlopidine: quo vadis? Subarachnoid hemorrhage.
Ono H, Mizukami M, Kitamura K, Kikuchi H. Ono H, et al. Agents Actions Suppl. 1984;15:259-72. Agents Actions Suppl. 1984. PMID: 6385650 Clinical Trial. No abstract available.
[Pathophysiology and treatment of thrombosis. (2) The effect of ticlopidine on TIA compared with aspirin. A double-blind, 12-month and open 24-month follow-up study].
Tohgi H, Murakami M. Tohgi H, et al. Nihon Naika Gakkai Zasshi. 1987 Jan;76(1):49-52. doi: 10.2169/naika.76.49. Nihon Naika Gakkai Zasshi. 1987. PMID: 3553381 Clinical Trial. Japanese. No abstract available.
Canadian American ticlopidine study (cats) in thromboembolic stroke.
Gent M, Ellis D. Gent M, et al. Agents Actions Suppl. 1984;15:283-96. Agents Actions Suppl. 1984. PMID: 6385653 Clinical Trial.
Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
Biller J. Biller J. J Neurol Sci. 2009 Sep 15;284(1-2):1-9. doi: 10.1016/j.jns.2009.04.001. Epub 2009 Apr 19. J Neurol Sci. 2009. PMID: 19380153 Review.
MATCH results: implications for the internist.
Lutsep HL. Lutsep HL. Am J Med. 2006 Jun;119(6):526.e1-7. doi: 10.1016/j.amjmed.2005.10.047. Am J Med. 2006. PMID: 16750967 Review.

See all similar articles

Cited by

Antiplatelet regimens after ischemic stroke or transient ischemic attack: a systematic review and updated network meta-analysis.
Jung SJ, Kim BJ, Kim CK, Shim SR, Jung JM. Jung SJ, et al. Ann Transl Med. 2022 Mar;10(5):245. doi: 10.21037/atm-21-3748. Ann Transl Med. 2022. PMID: 35402589 Free PMC article.
Ticlopidine hydrochloride use and threatened stroke.
Rothrock JF, Hart RG. Rothrock JF, et al. West J Med. 1994 Jan;160(1):43-7. West J Med. 1994. PMID: 8128701 Free PMC article.
Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
Niu PP, Guo ZN, Jin H, Xing YQ, Yang Y. Niu PP, et al. BMJ Open. 2016 Mar 17;6(3):e009013. doi: 10.1136/bmjopen-2015-009013. BMJ Open. 2016. PMID: 26988347 Free PMC article.
Antiplatelet therapy in the prevention of stroke.
Easton JD. Easton JD. Drugs. 1991;42 Suppl 5:39-50. doi: 10.2165/00003495-199100425-00007. Drugs. 1991. PMID: 1726215 Review.
Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.
Sudlow CL, Mason G, Maurice JB, Wedderburn CJ, Hankey GJ. Sudlow CL, et al. Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD001246. doi: 10.1002/14651858.CD001246.pub2. Cochrane Database Syst Rev. 2009. PMID: 19821273 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information